You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 4,038,142

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,038,142

Title:	Isolation and characterization of phenotypes of mycobacteria
Abstract:	The disclosure relates to a process of preparing a culture of mycobacteria by culturing mycobacteria on a liquid medium capable of dissociating mycobacteria into phenotypes, the culturing being carried out under partial anaerobic conditions and at a pH between 4.5 and 8.5.
Inventor(s):	Turcotte; Raymond (Montreal, CA), Quevillon; Marc (Ville D\'Anjou, CA)
Assignee:	Institut Armand Frappier (Ville de Laval, CA)
Application Number:	05/582,376
Patent Claims:	1. Process which comprises culturing a mycobacteria under partial anaerobic conditions in culture bottles containing a liquid medium selected from the group consisting of Sauton's medium, Long's medium, Proskauer and Beck's medium and Middlebrook's medium, said liquid medium partially filling said culture bottles, said culture bottles being tightly closed and incubated on their flat side at 37.5.degree. C during 14 to 21 days, the pH of said culture medium being maintained between 4.5 and 8.5, said culturing being carried out during about 14 to 21 days, thereby obtaining surface bacterial pellicles consisting of a mixture of smooth, filamentous and rough bacterial islets, respectively constituting Phenotypes 1, 2 and 3 of said mycobacteria, separately subculturing each of said Phenotypes 1, 2 and 3 in new supply of said liquid medium and isolating each of said Phenotypes 1, 2 and 3 in pure state. 2. Process according to claim 1, wherein said mycobacteria are selected from the group consisting of all substrains of Bacillus Calmette-Guerin (BCG), M. tuberculosis (H37Rv), M. kansasii (P-8), one scotochromogen (P-5) and M. intracellulare (P-2). 3. Process according to claim 2, wherein said mycobacteria include all substrains of BCG.

Details for Patent 4,038,142

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Teknika Llc	TICE BCG	bcg live	For Injection	102821	06/21/1989	⤷ Try a Trial	2040-01-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.